Older adults with acute myeloid leukemia treated with intensive chemotherapy: "old" prognostic algorithms may not apply

被引:4
作者
Stone, Richard M. [1 ]
Lindsley, Coleman [1 ]
机构
[1] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
关键词
IDH2; MUTATIONS; RELEVANCE; DECISION; THERAPY; AML;
D O I
10.3324/haematol.2018.201848
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1758 / 1759
页数:2
相关论文
共 19 条
[1]   Long-Term Results in Patients with Acute Myeloid Leukemia (AML): The Influence of High-Dose AraC, G-CSF Priming, Autologous Transplantation, Prolonged Maintenance, Age, History, Cytogenetics, and Mutation Status. Data of the AMLCG 1999 Trial. [J].
Buchner, Thomas ;
Berdel, Wolfgang E. ;
Haferlach, Claudia ;
Schnittger, Susanne ;
Haferlach, Torsten ;
Serve, Hubert ;
Mueller-Tidow, Carsten ;
Braess, Jan ;
Spiekermann, Karsten ;
Kienast, Joachim ;
Mesters, Rolf ;
Volpert, Sarah ;
Staib, Peter ;
Grueneisen, Andreas ;
Kern, Wolfgang ;
Reichle, Albrecht ;
Ludwig, Wolf-Dieter ;
Maschmeyer, Georg ;
Balleisen, Leopold ;
Eimermacher, Hartmut ;
Aul, Carlo ;
Giagounidis, Aristoteles ;
Rasche, Herbert ;
Hehlmann, Ruediger ;
Lengfelder, Eva ;
Koepcke, Wolfgang ;
Krug, Utz O. ;
Sauerland, Maria Cristina ;
Heinecke, Achim ;
Woermann, Bernhard J. ;
Hiddemann, Wolfgang .
BLOOD, 2009, 114 (22) :200-201
[2]   Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML [J].
DiNardo, C. D. ;
Stein, E. M. ;
de Botton, S. ;
Roboz, G. J. ;
Altman, J. K. ;
Mims, A. S. ;
Swords, R. ;
Collins, R. H. ;
Mannis, G. N. ;
Pollyea, D. A. ;
Donnellan, W. ;
Fathi, A. T. ;
Pigneux, A. ;
Erba, H. P. ;
Prince, G. T. ;
Stein, A. S. ;
Uy, G. L. ;
Foran, J. M. ;
Traer, E. ;
Stuart, R. K. ;
Arellano, M. L. ;
Slack, J. L. ;
Sekeres, M. A. ;
Willekens, C. ;
Choe, S. ;
Wang, H. ;
Zhang, V. ;
Yen, K. E. ;
Kapsalis, S. M. ;
Yang, H. ;
Dai, D. ;
Fan, B. ;
Goldwasser, M. ;
Liu, H. ;
Agresta, S. ;
Wu, B. ;
Attar, E. C. ;
Tallman, M. S. ;
Stone, R. M. ;
Kantarjian, H. M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (25) :2386-2398
[3]   Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel [J].
Doehner, Hartmut ;
Estey, Elihu ;
Grimwade, David ;
Amadori, Sergio ;
Appelbaum, Frederick R. ;
Buechner, Thomas ;
Dombret, Herve ;
Ebert, Benjamin L. ;
Fenaux, Pierre ;
Larson, Richard A. ;
Levine, Ross L. ;
Lo-Coco, Francesco ;
Naoe, Tomoki ;
Niederwieser, Dietger ;
Ossenkoppele, Gert J. ;
Sanz, Miguel ;
Sierra, Jorge ;
Tallman, Martin S. ;
Tien, Hwei-Fang ;
Wei, Andrew H. ;
Lowenberg, Bob ;
Bloomfield, Clara D. .
BLOOD, 2017, 129 (04) :424-447
[4]   Consensus-based definition of unfitness to intensive and non-intensive chemotherapy in acute myeloid leukemia: a project of SIE, SIES and GITMO group on a new tool for therapy decision making [J].
Ferrara, F. ;
Barosi, G. ;
Venditti, A. ;
Angelucci, E. ;
Gobbi, M. ;
Pane, F. ;
Tosi, P. ;
Zinzani, P. ;
Tura, S. .
LEUKEMIA, 2013, 27 (05) :997-999
[5]   The prognostic significance of IDH2 mutations in AML depends on the location of the mutation [J].
Green, Claire L. ;
Evans, Catherine M. ;
Zhao, Lu ;
Hills, Robert K. ;
Burnett, Alan K. ;
Linch, David C. ;
Gale, Rosemary E. .
BLOOD, 2011, 118 (02) :409-412
[6]   Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials [J].
Grimwade, David ;
Hills, Robert K. ;
Moorman, Anthony V. ;
Walker, Helen ;
Chatters, Stephen ;
Goldstone, Anthony H. ;
Wheatley, Keith ;
Harrison, Christine J. ;
Burnett, Alan K. .
BLOOD, 2010, 116 (03) :354-365
[7]   Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry [J].
Juliusson, Gunnar ;
Antunovic, Petar ;
Derolf, Asa ;
Lehmann, Soren ;
Mollgard, Lars ;
Stockelberg, Dick ;
Tidefelt, Ulf ;
Wahlin, Anders ;
Hoglund, Martin .
BLOOD, 2009, 113 (18) :4179-4187
[8]   Geriatric assessment predicts survival for older adults receiving induction chemotherapy for acute myelogenous leukemia [J].
Klepin, Heidi D. ;
Geiger, Ann M. ;
Tooze, Janet A. ;
Kritchevsky, Stephen B. ;
Williamson, Jeff D. ;
Pardee, Timothy S. ;
Ellis, Leslie R. ;
Powell, Bayard L. .
BLOOD, 2013, 121 (21) :4287-4294
[9]  
Leith CP, 1997, BLOOD, V89, P3323
[10]   Acute myeloid leukemia ontogeny is defined by distinct somatic mutations [J].
Lindsley, R. Coleman ;
Mar, Brenton G. ;
Mazzola, Emanuele ;
Grauman, Peter V. ;
Shareef, Sarah ;
Allen, Steven L. ;
Pigneux, Arnaud ;
Wetzler, Meir ;
Stuart, Robert K. ;
Erba, Harry P. ;
Damon, Lloyd E. ;
Powel, Bayard L. ;
Lindeman, Neal ;
Steensma, David P. ;
Wadleigh, Martha ;
DeAngelo, Daniel J. ;
Neuberg, Donna ;
Stone, Richard M. ;
Ebert, Benjamin L. .
BLOOD, 2015, 125 (09) :1367-1376